Brachytherapy Market Size, Share & Trends Report

Brachytherapy Market Size, Share & Trends Analysis Report By Type (High Dose Rate, Low Dose Rate), By Application (Prostate, Breast, Gynecological Cancer), By Region, And Segment Forecasts, 2019 - 2025

  • Published Date: Jan, 2019
  • Base Year for Estimate: 2017
  • Report ID: GVR-1-68038-618-9
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2017
  • Number of Pages: 120

Report Overview

The global brachytherapy market size was valued at USD 348.8 million in 2017. It is expected to register a CAGR of 4.6% over the forecast period from 2018 to 2025. According to the World Health Organization (WHO), cancer is one of the leading causes of morbidity and mortality across the globe. More than 70% of cancer-related deaths occur in low- and middle-income countries. The American Cancer Society stated that these countries have an increasing number of cancer patients and they lack access to radiation therapy. This factor is expected to offer new opportunities to the market players present in these regions.

Technological developments in the field of oncology treatment and R&D initiatives undertaken by the key players are some of the major growth drivers for this market. In addition, the companies are opting for acquisitions of smaller players to spread their regional outreach. For instance, iCAD markets the eBx system in the U.S. through its subsidiary Xoft. iCAD stated with over 12,000 installation opportunities for tomosynthesis systems in the U.S., there is a significant future opportunity for CAD and density assessment solutions for tomosynthesis.

U.S. brachytherapy market

According to the International Agency for Research on cancer, more than 15 million people are suffering from cancer worldwide at present. This number is expected to rise to 24 million by 2035. It is also estimated that 23.6 million new cancer cases will be diagnosed by 2030. Radiation therapy is used to palliate symptoms, cure localized cancer, and prevent cancer cells from spreading in case of incurable cancer. Demand for radiation therapy is expected to increase over the forecast period. The demand is also expected to witness growth in the U.S. as radiotherapy is considered as a critical cancer treatment.

In Europe, the EU Science Hub has estimated that the number of new cancer cases in the region is anticipated to increase rapidly due to demographic changes. Radiotherapy is expected to be the most preferred treatment option in such cases. According to the EU Science Hub, by 2018 there will be 3.9 million new cases and more than 1.9 million deaths due to cancer in Europe. In addition, radiotherapy is vital for the effective treatment of the majority of cancers in middle- and low-income countries. These factors are anticipated to bode well for the growth of the market for brachytherapy in the near future.

Type Insights

Radiation therapy can be used for prophylactic, palliative, or curative treatment. It can also be used as monotherapy or as an adjuvant with surgery, immunotherapy, and chemotherapy. The wide range of applications of radiotherapy has increased its adoption by physicians. The latest advancements in radiation therapy allow the delivery of a high amount of dose to the target area with minimum damage to nearby healthy tissues. This has increased the chances of localized tumor control and has improved cure rates, leading to an increase in demand for radiation therapy.

Key segments analyzed in this study are Low-Dose Rate (LDR) and High-Dose Rate (HDR) brachytherapy. HDR held the largest market share in terms of revenue in 2017. New product introductions and technological improvements are anticipated to bode well for overall market growth over the forecast period.

Application Insights

Prostate cancer held the dominant market share in 2017 due to the promising applications of brachytherapy in cancer treatment. On the other hand, breast cancer brachytherapy treatment is expected to witness the fastest CAGR over the forecast period due to increasing prevalence globally.

Global brachytherapy market

Recent advances in imaging technology have made this therapy more effective. In HDR brachytherapy, patients receive five weeks of external beam radiation therapy, followed by one to three sessions. In the treatment of prostate cancer, it allows safe escalation of the dosage to the tumor, while minimizing the dosage to surrounding healthy organs. 

Regional Insights

North America held the largest market share in 2017. Brachytherapy is widely used in North America due to the advantages it offers over traditional methods as it is comparatively safer and efficient cancer treatment. According to the American Cancer Society, in 2018, more than 2 million new cancer cases will be diagnosed in the U.S. The healthcare reforms in the U.S. have improved access and coverage for the population and they aim at increasing the efficiency of the health care system.

In Canada, Health Canada ensures the safety of medical devices and it verifies the specifications of medical devices mentioned by manufacturers. Health Canada has established the Canadian Patient Safety Institute (CPSI) to ensure patient safety. While the Canadian Nuclear Safety Commission (CNSC) ensures that the radiation received by the patients is under the supervision of qualified medical practitioners.

Asia Pacific Brachytherapy market is poised to witness the highest CAGR during the forecast period from 2018 to 2025. The region accounts for over 60% of the world population and half the global burden of cancer. The prevalence of cancer is rising pertaining to an unhealthy lifestyle. In addition, limited access to technologically advanced cancer treatments offers a wide scope for the market players.

Key Companies & Market Share Insights

Key market players have been undertaking various strategies to expand and strengthen their presence across the globe. As cancer care completely relies on innovations and R&D, the market is likely to witness significant growth in the forthcoming years. Some of the key players opt for mergers and partnerships to capture the untapped markets. With rapid digitization in the field of medicine, more companies are focusing on integrated applications of hardware and software to develop next-generation oncology treatment solutions.

Some of the well-established companies in this market are Eckert & Ziegler BEBIG; IsoRay Medical, Inc.; Elekta AB; and Varian Medical Systems, Inc. These players have been present in the market for more than 35 years. They already have a well-established network of suppliers and customers, which helps in strengthening their market position. Additionally, some of the major companies also operate in other business domains. Hence, most often they are able to invest huge amounts for R&D activities.

Brachytherapy Market Report Scope

Report Attribute


Market size value in 2020

USD 508.3 million

Revenue forecast in 2025

USD 452.3 million

Growth Rate

CAGR of 4.6% from 2018 to 2025

Base year for estimation


Historical data

2014 - 2017

Forecast period

2018 - 2025

Quantitative units

Revenue in USD million and CAGR from 2018 to 2025

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

Segments covered

Level, application, material, product by type, product by style, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; Japan; China; Brazil; Mexico; South Africa

Key companies profiled

Varian Medical Systems, Inc.; C. R. BARD, Inc.; Elekta AB; IsoRay Medical, Inc.; Eckert & Ziegler BEBIG; iCAD, Inc.; CIVCO Medical Solutions; Theragenics Corporation

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global brachytherapy market report based on type, application, and region:

  • Type Outlook (Revenue, USD Million, 2014 - 2025)

    • High Dose Rate (HDR)

    • Low Dose Rate (HDR)

  • Application Outlook (Revenue, USD Million, 2014 - 2025)

    • Prostate Cancer

    • Gynecological Cancer

    • Breast Cancer

    • Others

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • The U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities